Advertisement

Picture EBD Group Startup Spotlight at BIO-Europe 2023 650x100px
Document › Details

AstraZeneca plc. (1/9/23). "Press Release: AstraZeneca to Acquire CinCor Pharma to Strengthen Cardiorenal Pipeline".

Organisations Organisation AstraZeneca plc (LSE: AZN)
  Group AstraZeneca (Group)
  Organisation 2 CinCor Pharma Inc.
  Group AstraZeneca (Group)
Products Product baxdrosat (CIN-107)
  Product 2 drug development
Index term Index term CinCor Pharma–AstraZeneca: investment, 202301– acquisition cash tender offer upfront $1.3b ($26/share) + up to $500m CVR at $10/share
Persons Person Pangalos, Menelas (AstraZeneca 201303 EVP Innovative Medicines + Early Development Biotech Unit)
  Person 2 de Garidel, Marc (Abivax 202307 CEO before CinCor Pharma + Corvidia + Ipsen + Amgen + Eli Lilly)
     


   
Record changed: 2023-09-04

Advertisement

Picture EBD Group BIO-Europe 2023 Munich BEU23 650x200px

More documents for AstraZeneca (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top